Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study

BACKGROUND: The aim of this study was to compare the efficacy, safety, costs, and cost-effectiveness of biphasic insulin aspart 30 (BIAsp 30) with NPH plus regular human insulin (NPH/Reg) in patients with type 2 diabetes mellitus (T2DM). METHODS: It was a Single-center, parallel-group, randomized, c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Endocr Disord
Main Authors: Farshchi, Amir, Aghili, Rokhsareh, Oskuee, Maryam, Rashed, Marjan, Noshad, Sina, Kebriaeezadeh, Abbas, Kia, Maryam, Esteghamati, Alireza
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4899904/
https://ncbi.nlm.nih.gov/pubmed/27278922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-016-0116-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados